Fatima Noor
Aug 17, 2026
The chemical industry is witnessing a transformative shift as Copenhagen-based Again acquires San Diego’s Genomatica. This strategic merger combines advanced carbon utilization technology with decades of biomanufacturing expertise.
Together the entities estimate a combined capacity to divert up to 85 million tons of CO2 per year. This figure reflects both direct carbon capture and indirect emission avoidance across their respective technologies. Procurement managers must understand how this scale impacts the availability of sustainable biobased chemicals.
The acquisition integrates Genomatica’s twenty-eight years of fermentation data into Again’s modern platform. This synergy accelerates the production of high-demand molecules like 1,4-butanediol and nylon precursors. Buyers will see a more robust supply chain for low-carbon industrial materials in the coming years.
This development signals that biobased alternatives are moving from niche applications to mainstream industrial use. Traders and importers should prepare for new sourcing dynamics driven by massive carbon diversion capabilities. The merged entity aims to redefine sustainability standards in the global chemical market.
The estimate of 85 million tons of annual CO2 diversion represents a significant milestone for the sector. This capacity stems from the integration of direct carbon capture methods with biological synthesis processes. Again utilizes captured CO2 as a primary feedstock for producing chemical building blocks efficiently.
Genomatica contributes by optimizing microbial strains that convert renewable resources into target molecules with minimal emissions. The combination creates a hybrid model that maximizes carbon efficiency across the entire production lifecycle. Procurement teams can leverage this data to meet stringent corporate sustainability targets and regulatory mandates.
Indirect emission avoidance plays a crucial role in achieving this massive diversion potential. By replacing fossil-based production routes with biobased alternatives the merged entity prevents substantial upstream emissions. This holistic approach offers buyers a verifiable path to reducing their overall carbon footprint significantly.
The demand for sustainable alternatives to petrochemicals is growing rapidly across various industrial sectors. 1,4-butanediol remains a critical molecule used extensively in the production of polyurethanes and spandex fibers. Genomatica’s pioneering work in biobased BDO provides a drop-in replacement with identical performance characteristics.
Nylon precursors represent another high-volume category where biobased solutions are gaining significant traction. These materials are essential for the automotive and textile industries which face intense pressure to decarbonize. The acquisition ensures continued innovation and supply stability for these essential industrial intermediates.
Buyers should evaluate these molecules based on their total lifecycle emissions and cost competitiveness. Biobased 1,4-butanediol offers a compelling value proposition by reducing environmental impact without compromising quality. This ease of transition simplifies adoption for manufacturers seeking to meet sustainability goals effectively.
Traditional chemical manufacturing relies heavily on fossil feedstocks and energy-intensive processes. The integration of CO2 utilization transforms waste carbon into valuable industrial chemicals while reducing emissions. Procurement professionals can now source materials from facilities equipped with advanced carbon capture infrastructure.
This shift diversifies the supply chain by reducing dependence on volatile oil and gas markets. It also enhances resilience against geopolitical disruptions and regulatory changes affecting fossil fuel extraction. Traders will see new production hubs emerging in regions with abundant renewable energy and carbon sources.
The merged entity’s ability to divert 85 million tons of CO2 annually underscores the scalability of this model. Large-scale carbon utilization requires robust infrastructure and efficient logistics networks to support global distribution. Buyers benefit from a more stable and transparent supply chain for essential chemical building blocks.
Government policies worldwide are actively promoting the adoption of biobased chemicals over traditional petrochemicals. The European Union and other major economies are implementing stricter regulations on carbon emissions and fossil fuel usage. These regulatory pressures create a highly favorable environment for companies like Again and Genomatica.
Corporate buyers face direct mandates from their executive boards to increase the share of sustainable materials. Procurement managers must navigate complex compliance landscapes while maintaining cost competitiveness and product quality. The acquisition provides buyers with a reliable partner capable of meeting these dual objectives effectively.
Sustainability reporting requirements are becoming more stringent across all industrial sectors globally. Companies need accurate data on the environmental impact of their raw materials to comply with these standards. The combined expertise of Again and Genomatica offers robust solutions for tracking and verifying carbon reductions accurately.
Despite the immense potential scaling carbon capture and biomanufacturing operations presents significant challenges. Building new facilities requires substantial capital investment and long-term financial commitment from stakeholders. Investors demand clear pathways to profitability before supporting large-scale expansion projects in this sector.
Securing consistent and cost-effective feedstocks remains a critical hurdle for the biobased chemical industry. Agricultural residues and waste sugars often suffer from supply chain inconsistencies and seasonal variations. The merged entity must navigate these logistical complexities to maintain reliable production volumes year-round.
Market adoption also depends on the price competitiveness of biobased alternatives compared to petrochemicals. Volatility in oil prices can influence the economic viability of sustainable production methods temporarily. Buyers must consider long-term value propositions rather than just short-term purchase prices when evaluating these materials.
Procurement leaders must update their sourcing strategies to incorporate these emerging biobased supply chains immediately. Engaging with suppliers who offer verified sustainable alternatives will secure priority access to new materials. Building strong relationships with innovators like Again ensures stability in a rapidly evolving market landscape.
Cross-functional collaboration between procurement sustainability and research departments is essential for success. Companies need to identify which petrochemical ingredients they can replace with biobased equivalents without compromising quality. The transition requires careful testing but offers significant long-term strategic advantages for early adopters.
Investing in digital tools to measure and report the carbon footprint of chemical purchases is crucial. This data supports regulatory compliance and enhances brand reputation among environmentally conscious consumers. Procurement teams play a vital role in driving the industry toward a more sustainable and resilient future.
The acquisition of Genomatica by Again signals a mature phase for the biobased chemicals sector. The potential to divert 85 million tons of CO2 annually demonstrates the massive scale of this opportunity. Buyers and traders must adapt to this new reality to remain competitive in the global market.
Biobased molecules like 1,4-butanediol and nylon precursors will increasingly dictate supply chain dynamics. Companies that proactively integrate these sustainable materials into their portfolios will gain a distinct competitive edge. The future of chemical trading belongs to those who embrace biological manufacturing and advanced carbon utilization. Ready to source Lactic Acid from verified global suppliers? Explore competitive offers on our platform today.
Featured Product
Found this useful?
Continue Reading
The Again and Genomatica deal coincides with the EU's Biotech Act II. This policy mobilizes billions to cement domestic biobased chemicals supply chains and mirror US reshoring efforts.
The brief positive naphtha-ethylene spread in August follows weeks of negative margins. This suggests the shift may be temporary rather than a durable recovery for ethylene producers.
The Again and Genomatica acquisition aligns with the US BIOSECURE Act and a $15 billion federal commitment to domestic bio-infrastructure. This reshoring push reduces dependence on overseas chemical production for global buyers.
